Deals Shaping The Medical Industry, August 2020
Derived from Biomedtracker, the Deal-Making column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing.
You may also be interested in...
Sweden's InDex To Stay Afloat Thanks To Mystery Merger Partner
The writing was on the wall for InDex after cobitolimod flopped for ulcerative colitis but that should soon been scrubbed off now a reverse-merger candidate has been identified to save the Stockholm-based biotech from liquidation.
Clasado, Probi Funded Study Shows Synergistic Effect Of Synbiotic Combination
The combination of Clasado's Bimuno GOS prebiotic and Probi's Defendum probiotic has been shown to significantly increase lactate levels and increase short chain fatty acid butyrate by 26% - “two important gut health promoting components that are also associated with supporting immune health,” Clasado said.
Qunol Acquisition Gets Sanofi CHC Off To Flying Start
Sanofi CHC sales up 9% in Q1 driven by addition of US healthy aging supplement brand Qunol. Separately, the Paris-based firm has reached an agreement in principle to resolve the vast majority of Zantac personal injury state court cases in the US.
| Table |
|---|